Orthox Ltd.
This article was originally published in Start Up
Executive Summary
UK-based Orthox Ltd. has developed a meniscus replacement technology derived from the high-strength silk proteins found in spider web. The company is hoping to offer the best long-term, load-bearing solution for this underserved segment of the orthopedics market.
You may also be interested in...
Start-Up Previews (09/2011)
This Month's Profile Group: Cartilage Repair: Opportunities In Motion-Preserving Orthopedics, features profiles of Articulinx, Carticept Medical and Orthox. Plus these Start-Ups Across Health Care: Ellipse Technologies, JDP Therapeutics, NuMe Health and SironRX Therapeutics.
Carticept Medical Inc.
Carticept Medical Inc. is working to become the first company with a synthetic cartilage replacement device for use in the earlier stages of knee OA that allows immediate weight bearing, with future applications in the hand and foot. The company also is awaiting 510(k) clearance for its Navigator all-in-one orthopedic injection system combined with ultrasound guidance.
Articulinx Inc.
Osteoarthritis affects almost 21 million Americans aged 25 or older, and is most prevalent in the hand. The need for an alternative to long-term drug therapy for treating early stage hand OA is a vastly underserved market that Silicon Valley-based Articulinx Inc. hopes to address with its Intercarpometacarpal Cushion, a spacer device used to augment cartilage in the basal joint of the thumb.